Skip to main content

Table 2 Symptoms in critical patients with HFRS

From: Clinical characteristics and outcomes in critical patients with hemorrhagic fever with renal syndrome

Symptoms

Survivors (n = 46)

Non-survivors (n = 29)

P valuea

Dyspnea, n (%)

12 (26.1)

14 (48.3)

.049

Fever, n (%)

46 (100)

29 (100)

1.000

Nausea, n (%)

35 (76.1)

21 (72.4)

.722

Vomiting, n (%)

27 (58.7)

17 (58.6)

.995

Anepithymia, n (%)

12 (26.1)

4 (13.8)

.206

Hematemesis, n (%)

5 (10.9)

2 (6.9)

.866

Dark stools, n (%)

7 (15.2)

4 (13.8)

.865

Abdominal distention, n (%)

23 (50)

13 (44.8)

.662

Cough, n (%)

17 (37)

6 (20.7)

.137

Expectoration, n (%)

13 (28.3)

4 (13.8)

.145

Spasm, n (%)

3 (6.5)

3 (10.3)

.875

Agitation, n (%)

16 (34.8)

24 (82.8)

< .001

Fatigue, n (%)

21 (45.7)

10 (34.5)

.339

Lethargy, n (%)

11 (23.9)

10 (34.5)

.323

Hemoptysis, n (%)

2 (4.3)

2 (6.9)

1.000

Blurred vision, n (%)

3 (6.5)

3 (10.3)

.875

Chills, n (%)

10 (21.7)

9 (31)

.367

Diarrhea, n (%)

9 (19.6)

6 (20.7)

.906

Stomachache, n (%)

19 (41.3)

11 (37.9)

.772

Headache, n (%)

22 (47.8)

10 (34.5)

.255

Dizziness, n (%)

13 (28.3)

9 (31)

.797

Lumbago, n (%)

30 (65.2)

14 (48.3)

.147

Chest distress, n (%)

22 (47.8)

13 (44.8)

.800

Short breath, n (%)

22 (47.8)

17 (58.6)

.362

  1. aSurvivors vs. non-survivors.